Nirmatrelvir/ritonavir: real world drug-drug interaction management experience

被引：0
|
作者：
Bukhari, Shahid [1 ]
Hughes, Stephen [1 ]
Mughal, Nabeela [1 ]
Moore, Luke S. P. [1 ,2 ,3 ]
Davies, Gary [1 ]
Zhang, Adrian Varghas [2 ]
Ng, Megan [2 ]
Karagozlu, Zekiye [2 ]
Boffito, Marta [1 ,2 ]
机构：
[1] Chelsea & Westminster Hosp Fdn Trust, London, England
[2] Imperial Coll London, London, England
[3] Imperial Coll Healthcare NHS Trust, North West London Pathol, London, England
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2024年 / 22卷 / 09期
关键词：
Nirmatrelvir/ritonavir; drug-drug interactions; COVID-19; Paxlovid; real world;
D O I：
10.1080/14787210.2024.2389884
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
BackgroundIn the UK, a regional vertical system for the delivery of COVID-19 medicines has been in place. This enabled centralization of expertise in risk stratification of patients, and in understanding and mitigating drug-drug interactions.Research design and methodsWe analyzed real-world drug-drug interactions in adult patients referred for nirmatrelvir/ritonavir therapy across one such geographic area covering 2.2 million London citizens.ResultsAmong 208 who received NMV/r therapy, we identified 184 potential DDIs, 8% precluded nirmatrelvir/ritonavir use, 53% required management, but 56% of these did not have documented advice to hold therapy.ConclusionsThis highlights the need to maintain and develop pathways for clinical pharmacology expertise in COVID-19 management.
引用
收藏
页码：781 / 783
页数：3
相关论文
共 50 条
  • [1] Experience of a nirmatrelvir/ritonavir drug-drug interaction expert advice service
    Lemaitre, Florian
    Tron, Camille
    Lalanne, Sebastien
    Franck, Benedicte
    Boglione-Kerrien, Christelle
    Taieb, Fabrice
    Verdier, Marie-Clemence
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 6 - 7
  • [2] Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (01) : 45 - 48
  • [3] Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir
    Hendrick, Victoria
    Pohorylo, Erast
    Merchant, Lubna
    Gerhart, Jackie
    Arham, Iqra Naz
    Draica, Florin
    Quercia, Romina
    Ayoub, Ayman
    Mehta, Reema
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (12) : 2545 - 2561
  • [4] Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    de Oliveira, Luciana Mello
    Dal Pizzol, Tatiane da Silva
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 307 - 308
  • [5] A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir
    Lemaitre, F.
    Boland, L.
    Tron, C.
    Ruelland, A. L.
    Lelong-Boulouard, V.
    Baklouti, S.
    Goirand, F.
    Gambier, N.
    Boglione-Kerrien, C.
    Franck, B.
    Lalanne, S.
    Devresse, A.
    Briol, S.
    De Greef, J.
    Haufroid, V.
    Verdier, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 58 - 59
  • [6] Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
    Luciana Mello de Oliveira
    Tatiane da Silva Dal Pizzol
    Journal of Medical Toxicology, 2023, 19 : 307 - 308
  • [7] Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
    Morganne Sindelar
    Daniel McCabe
    Elisabeth Carroll
    Journal of Medical Toxicology, 2023, 19 : 309 - 309
  • [8] Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 309 - 309
  • [9] Nirmatrelvir+ritonavir/tacrolimusDiarrhoea following drug-drug pharmacokinetic interaction: case report
    Reactions Weekly, 2023, 1979 (1) : 349 - 349
  • [10] Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients
    Xu, Xueyin
    Zhang, Huanxi
    Liu, Longshan
    Fu, Qian
    Wu, Chenglin
    Lin, Xiaobin
    Tang, Kejing
    Wang, Changxi
    Chen, Pan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (08) : 1219 - 1227
12345